Correction for Pamplona et al., Anti-inflammatory lipoxin A₄ is an endogenous allosteric enhancer of CB₁ cannabinoid receptor

PHARMACOLOGY Correction for “Anti-inflammatory lipoxin A₄ is an endogenous allosteric enhancer of CB₁ cannabinoid receptor,” by Fabricio A. Pamplona, Juliano Ferreira, Octávio Menezes de Lima, Jr., Filipe Silveira Duarte, Allisson Freire Bento, Stefânia Forner, Jardel G. Villarinho, Luigi Bellochio, Carsten T. Wotjak, Raissa Lerner, Krisztina Monory, Beat Lutz, Claudio Canetti, Isabelle Matias, João Batista Calixto, Giovanni Marsicano, Marilia Z. P. Guimarães, and Reinaldo N. Takahashi, which appeared in issue 51, December 18, 2012, of Proc Natl Acad Sci USA (109:21134–21139; first published November 12, 2012; 10.1073/pnas.1202906109).

The authors note that the author name Luigi Bellochio should instead appear as Luigi Bellocchio. The corrected author line appears below. The online version has been corrected.